The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials.

MLA

Cui, Jianlan, et al. “The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials.” PLoS ONE, vol. 8, no. 4, Apr. 2013, pp. 1–11. EBSCOhost, https://doi.org/10.1371/journal.pone.0062038.

APA

Cui, J., Cai, X., Zhu, M., Liu, T., & Zhao, N. (2013). The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials. PLoS ONE, 8(4), 1–11. https://doi.org/10.1371/journal.pone.0062038

Chicago

Cui, Jianlan, Xueya Cai, Min Zhu, Tianshu Liu, and Naiqing Zhao. 2013. “The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials.” PLoS ONE 8 (4): 1–11. doi:10.1371/journal.pone.0062038.